- Type / Class
- Equity / Common Stock
- Shares outstanding
- 123,850,680
- Total 13F shares
- 91,351,911
- Share change
- +4,270,650
- Total reported value
- $13,941,648,366
- Put/Call ratio
- 83%
- Price per share
- $152.65
- Number of holders
- 410
- Value change
- +$681,296,473
- Number of buys
- 191
- Number of sells
- 201
Quarterly Holders Quick Answers
What is CUSIP 40131M109?
CUSIP 40131M109 identifies GH - Guardant Health, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 40131M109:
Top shareholders of GH - Guardant Health, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
6.2%
|
7,621,237
|
$982,224,000 | — | 31 Dec 2020 | |
| SB INVESTMENT ADVISERS (UK) LTD |
13F
|
Company |
5.1%
|
6,337,960
|
$816,836,000 | — | 31 Dec 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.3%
|
5,323,941
|
$686,151,000 | — | 31 Dec 2020 | |
| MORGAN STANLEY |
13F
|
Company |
4%
|
4,939,884
|
$636,653,000 | — | 31 Dec 2020 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
2.9%
|
3,534,842
|
$455,570,000 | — | 31 Dec 2020 | |
| Clearbridge Investments, LLC |
13F
|
Company |
2.6%
|
3,177,088
|
$409,463,000 | — | 31 Dec 2020 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
2.4%
|
3,006,977
|
$387,539,000 | — | 31 Dec 2020 | |
| FMR LLC |
13F
|
Company |
2.2%
|
2,769,631
|
$356,950,000 | — | 31 Dec 2020 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
2,070,447
|
$266,839,000 | — | 31 Dec 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1.7%
|
2,065,970
|
$266,262,000 | — | 31 Dec 2020 | |
| Capital Research Global Investors |
13F
|
Company |
1.6%
|
2,032,763
|
$261,982,000 | — | 31 Dec 2020 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
1.3%
|
1,640,318
|
$211,404,000 | — | 31 Dec 2020 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.3%
|
1,619,719
|
$208,750,000 | — | 31 Dec 2020 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
1.3%
|
1,613,007
|
$207,884,000 | — | 31 Dec 2020 | |
| Capital International Investors |
13F
|
Company |
1.2%
|
1,495,702
|
$192,766,000 | — | 31 Dec 2020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.2%
|
1,432,374
|
$184,604,000 | — | 31 Dec 2020 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.2%
|
1,428,059
|
$184,048,000 | — | 31 Dec 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
1.1%
|
1,378,522
|
$177,662,000 | — | 31 Dec 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.1%
|
1,302,865
|
$167,913,000 | — | 31 Dec 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.93%
|
1,150,891
|
$148,326,000 | — | 31 Dec 2020 | |
| COATUE MANAGEMENT LLC |
13F
|
Company |
0.9%
|
1,118,537
|
$144,158,000 | — | 31 Dec 2020 | |
| BAMCO INC /NY/ |
13F
|
Company |
0.88%
|
1,089,983
|
$140,477,000 | — | 31 Dec 2020 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.87%
|
1,082,368
|
$139,496,000 | — | 31 Dec 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.84%
|
1,039,390
|
$133,956,000 | — | 31 Dec 2020 | |
| STATE STREET CORP |
13F
|
Company |
0.79%
|
984,183
|
$126,842,000 | — | 31 Dec 2020 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.76%
|
946,882
|
$122,034,000 | — | 31 Dec 2020 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.71%
|
876,029
|
$112,903,000 | — | 31 Dec 2020 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0.59%
|
733,566
|
$94,541,000 | — | 31 Dec 2020 | |
| NORGES BANK |
13F
|
Company |
0.54%
|
672,202
|
$86,633,000 | — | 31 Dec 2020 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.49%
|
609,602
|
$78,566,000 | — | 31 Dec 2020 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
0.47%
|
581,970
|
$75,004,000 | — | 31 Dec 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.47%
|
580,137
|
$74,768,000 | — | 31 Dec 2020 | |
| Chevy Chase Trust Holdings, LLC |
13F
|
Company |
0.45%
|
561,762
|
$72,398,000 | — | 31 Dec 2020 | |
| HealthCor Management, L.P. |
13F
|
Company |
0.44%
|
543,160
|
$70,002,000 | — | 31 Dec 2020 | |
| ARK Investment Management LLC |
13F
|
Company |
0.44%
|
540,537
|
$69,664,000 | — | 31 Dec 2020 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.43%
|
538,200
|
$69,363,000 | — | 31 Dec 2020 | |
| Senator Investment Group LP |
13F
|
Company |
0.4%
|
500,000
|
$64,440,000 | — | 31 Dec 2020 | |
| Ardevora Asset Management LLP |
13F
|
Company |
0.38%
|
470,358
|
$60,620,000 | — | 31 Dec 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.35%
|
434,726
|
$56,029,000 | — | 31 Dec 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.34%
|
420,712
|
$54,222,000 | — | 31 Dec 2020 | |
| THRIVENT FINANCIAL FOR LUTHERANS |
13F
|
Company |
0.33%
|
408,085
|
$52,594,000 | — | 31 Dec 2020 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.32%
|
401,736
|
$51,775,000 | — | 31 Dec 2020 | |
| Invesco Ltd. |
13F
|
Company |
0.32%
|
397,547
|
$51,237,000 | — | 31 Dec 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.3%
|
372,157
|
$47,964,000 | — | 31 Dec 2020 | |
| Hitchwood Capital Management LP |
13F
|
Company |
0.28%
|
350,000
|
$45,108,000 | — | 31 Dec 2020 | |
| CARILLON TOWER ADVISERS, INC. |
13F
|
Company |
0.27%
|
335,487
|
$43,238,000 | — | 31 Dec 2020 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.27%
|
334,295
|
$43,084,000 | — | 31 Dec 2020 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.27%
|
330,446
|
$42,588,000 | — | 31 Dec 2020 | |
| Fiera Capital Corp |
13F
|
Company |
0.26%
|
325,141
|
$41,905,000 | — | 31 Dec 2020 | |
| FIL Ltd |
13F
|
Company |
0.26%
|
322,971
|
$41,625,000 | — | 31 Dec 2020 |
Institutional Holders of Guardant Health, Inc. - Common Stock (GH) as of Q1 2021
As of 31 Mar 2021,
Guardant Health, Inc. - Common Stock (GH) was held by
410 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
91,351,911 shares.
The largest 10 holders included
VANGUARD GROUP INC, FMR LLC, SB INVESTMENT ADVISERS (UK) LTD, BlackRock Inc., MORGAN STANLEY, Clearbridge Investments, LLC, VIKING GLOBAL INVESTORS LP, JENNISON ASSOCIATES LLC, FRED ALGER MANAGEMENT, LLC, and Nuveen Asset Management, LLC.
This page lists
411
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
399
Q1 2021 holders
410
Holder diff
11
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 Value $ | Q1 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.